The EU project PET3D (PET Imaging in Drug Design and Development) is a new Innovative Training Network (ITN) funded (€4M) by the European Commission under the H2020 – MSCA-ITN-2015 programme, and coordinated by Professor Matteo Zanda at the University of Aberdeen.
PET3D is run by a Consortium of Universities and Industries operating in the Pharma sector with the aim to provide excellent, interdisciplinary and cross-sectorial training in Drug Design and Development within an innovative PhD programme for 15 Early Stage Researchers (ESRs).
All of the ESRs recruited by PET3D will be exposed to a variety of highly complementary research environments spanning different therapeutic areas: oncology, cardiovascular, neuroscience and all of the ESRs will spend at least one secondment in a different country and will have the opportunity to attend training events and consortium meetings in all of the 7 countries involved in PET3D.
Applications are now open for two positions at CIC biomaGUNE, San Sebastián, Spain:
PhD fellow: ESR7 ‘Synthesis and preclinical investigation of boron-enriched gold nanoparticles: a pre-targeting approach to boron neutron capture therapy.’ Secondments: 6 months at University of Aberdeen (month 14), 4 months at Imanova, UK (month 35)
Deadline for application: 30 November 2016
PhD fellow: ESR8 ‘Development and evaluation of bispecific nanoparticles for T cell engagement (Nanobites): a targeted and multimodality approach to cancer therapy.’ Secondments: 2 months at Vrije Universiteit Brussel (month 16), 6 months at AstraZeneca, Sweden (month 28)
Deadline for application: 15 December 2016
For details of these positions, go to http://www.abdn.ac.uk/pet3d/recruitment/esr7-esr8-san/